CD47 and atherosclerosis: In addition, TSP-1-CD47 interaction redundantly inhibits antagonism NO (nitric oxide)-cGMP-cGKI axis, which plays a pro-atherogenic role in atherosclerosis development [45] (seeFig. 2).